The biotechnology company posted revenue of $142,100 in the period. Its adjusted revenue was $142,000. In the final minutes of trading on Thursday, ...
News
- Capricor: 3Q Earnings Snapshot
- Economic development — or a giveaway of tax dollars?
In San Antonio, downtown's tech district is the heart of the ecosystem. .... impact a single incubator has had on biotech's dense tissue of connections.
- Bellerophon Presents Data of Ongoing Phase 2/3 Study of INOpulse
The company will present data from Cohort 1 of its ongoing Phase 2/3 clinical trial of INOpulse in San Antonio, Texas. Bellerophon Therapeutics ...
- Analysts See $-0.18 EPS for Celcuity Inc. (CELC)
... 2019, also Bizjournals.com with their article: “Biotech startup Celcuity raises $23M in IPO – Minneapolis / St. Paul ... San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and ...
- Moderna: 3Q Earnings Snapshot
The biotechnology company posted revenue of $17 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks ...